Silicon Laboratories Inc. — Form 10-Q Summary
Reporting period: First quarter of fiscal 2011, three months ended April 2, 2011; comparative period ended April 3, 2010. The request metadata says “2010 Q1,” but the filing covers 2011 Q1. Amounts below are in U.S. dollars; financial statement amounts are in millions unless noted.
Business context and results
Silicon Laboratories designs mixed-signal integrated circuits and operates as a fabless semiconductor company, relying on third parties for wafer fabrication, assembly and testing. It serves communications, consumer, industrial, automotive, medical and power-management markets. In January 2011, it acquired Spectra Linear, a provider of timing ICs.
| Metric | Q1 2011 | Q1 2010 | Change / context |
|---|---|---|---|
| Revenue | $119.6 | $126.7 | Down 5.6%; unit volumes fell 13.2%, while average selling prices rose 9.4% |
| Gross profit / margin | $72.2 / 60.3% | $83.6 / 66.0% | Gross profit down 13.7%; margin fell 5.7 percentage points |
| Operating expenses | $67.2 | $57.9 | Up 16.0%; R&D and SG&A both increased |
| Operating income / margin | $4.9 / 4.1% | $25.7 / 20.3% | Material decline |
| Net income (loss) | $(2.0) | $21.1 | Basic and diluted EPS were $(0.04), versus $0.46 and $0.44, respectively |
| Cash from operations | $(2.6) | $31.1 | Working-capital changes contributed to the outflow |
| Cash and cash equivalents | $118.5 | — | Down from $138.6 at January 1, 2011 |
| Short-term investments | $203.8 | — | Cash plus short-term investments totaled $322.3 at quarter-end |
Financial position, cash flow and material changes
- Total assets were $733.5 million and total liabilities were $103.2 million at April 2, 2011. Current assets were $471.2 million versus current liabilities of $79.7 million. The filing does not provide a clear total debt balance; long-term obligations and other liabilities were $23.5 million.
- Cash and cash equivalents decreased by $20.1 million during the quarter. Investing activities used $7.2 million, including $27.5 million net cash for the Spectra Linear acquisition; financing activities used $10.2 million, including $7.2 million of payments on acquired debt.
- Operating cash flow was affected by a $17.8 million net outflow from changes in operating assets and liabilities. Accounts receivable rose to $58.5 million from $45.0 million; DSO increased to 44 days from 36. Inventory rose to $41.1 million from $39.5 million, while DOI improved to 78 days from 87.
- Revenue weakness was attributed primarily to weaker demand for consumer-oriented products. Gross margin also reflected product mix and Spectra Linear acquisition-related charges. R&D rose 18.2% to $35.4 million; SG&A rose 13.8% to $31.9 million. Management cited one-time acquisition-related personnel costs of about $1.6 million in R&D and $3.0 million in SG&A.
- The Spectra Linear purchase price was approximately $28.6 million, including estimated contingent consideration of $1.0 million; the contingent amount may reach $10 million depending on 2011 product revenue. The purchase-price allocation was preliminary. Goodwill increased by $4.9 million, and acquired identifiable intangibles totaled $18.0 million.
- Income tax expense was $7.7 million, producing a 134.3% effective tax rate, versus 19.0% in the prior-year quarter. The filing attributes the increase primarily to a tax charge related to an intercompany license of acquired technology and other nondeductible acquisition costs.
Outlook, risks and contingencies
- For fiscal Q2 2011, management expected revenue of $124–$130 million and diluted EPS of $0.24–$0.30. It expected R&D expense to rise in absolute dollars and SG&A to remain stable, excluding acquisition-related one-time costs. Fiscal 2011 capital expenditures were estimated at $15–$20 million.
- Management said existing cash and investment balances were sufficient for at least 12 months. This liquidity assessment excludes $17.0 million of long-term auction-rate securities at fair value ($19.6 million par), all subject to failed auctions and potentially inaccessible until redemption, resale or maturity. Management reported no other-than-temporary impairment at quarter-end.
- One customer, Samsung, exceeded 10% of revenue; three distributors represented 22%, 15% and 11%. International customers generated 86% of revenue. Key exposures include customer and product concentration, semiconductor cyclicality, price erosion, lengthy design-win and qualification cycles, and reliance on third-party manufacturing and logistics.
- The company identified potential supply-chain effects from the Japan earthquake and tsunami, including temporary disruption to certain specialty chemicals; it was qualifying alternative sources. It also cited geographic concentration of suppliers and customers in the Pacific Rim, including earthquake and geopolitical risks.
- An interest-rate swap had a $3.0 million fair-value liability. Its agreement requires at least $150 million in unencumbered cash and highly rated short-term investments or collateral may be required; no collateral had been posted. The company expected $1.8 million of accumulated swap losses to be reclassified to earnings over the next 12 months, offset by lower rent payments.
- Headquarters leases expose the company to potential first-dollar losses of up to $35.3 million and $40.0 million if specified sale proceeds fall short of purchase-option amounts. Securities class-action settlement appeals remained pending; insurers were to fund the settlement, but an adverse outcome if it does not survive appeal could create uncovered exposure. Other ordinary-course proceedings were not expected to have a material adverse effect.
Most important facts for investors to verify
- Whether Q2 revenue and EPS guidance was achieved, and whether consumer-product demand and unit volumes recovered.
- Whether gross-margin pressure and acquisition-related expenses persisted, and how Spectra Linear performed against its revenue milestones.
- Cash conversion and working-capital trends, especially receivables, DSO and inventory relative to demand.
- Availability and valuation of failed-auction securities, and compliance with the swap’s liquidity/collateral requirement.
- Customer and distributor concentration, outsourced supply-chain continuity, lease exposure and the status of the securities litigation appeals.